Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» An early arrival among ’17 biotech IPOs, AnaptysBio keeps to its range in successful $75M play
An early arrival among ’17 biotech IPOs, AnaptysBio keeps to its range in successful $75M play
An early arrival among ’17 biotech IPOs, AnaptysBio keeps to its range in successful $75M play
Submitted by
admin
on January 27, 2017 - 9:25am
Source:
Endpoints
News Tags:
AnaptysBio
IPOs
Headline:
An early arrival among ’17 biotech IPOs, AnaptysBio keeps to its range in successful $75M play
Do Not Allow Advertisers to Use My Personal information